Why Ethics Matter in the Debate Around Psychedelics | Neşe Devenot | TEDxMidAtlantic

Allegations and Concerns - Allegations of misreporting serious adverse events, including suicidal behavior, during clinical trials [5] - Concerns about a "therapy cult" dynamic within Lykos, potentially indoctrinating therapists and participants [9] - Lykos's therapy model, based on Stanislav Grof's teachings, involves reenacting interpersonal trauma, raising ethical concerns [14] - Specific instances of therapists engaging in abusive practices, such as pinning down patients, are documented [15] Regulatory and Ethical Issues - Opposition to Lykos Therapeutics' MDMA-assisted therapy application for PTSD due to safety and efficacy concerns [3] - The FDA granted a request to extend the open public hearing to address concerns about Lykos's therapy [8] - The argument that Lykos's intervention heightens risks for patients by promoting boundary violations by therapists [18] - The advisory committee outcome sent a message of validation to people who have been hurt [19] Company Practices - Lykos's therapy is described as nondirective and empathetic, but this is misleading [12] - Lykos claims its therapy reduces the risk of assault, but the intervention directly contributed to sexual and physical assaults by therapists [13] - Lykos's training will ensure that boundaries are maintained, but its intervention actually heightens the risks for for patients by promoting boundary violations by therapists [18]